Monica R Shah

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale
    M R Shah
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Am Heart J 141:528-35. 2001
  2. ncbi request reprint Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST
    M R Shah
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 141:908-14. 2001
  3. ncbi request reprint Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy
    M R Shah
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 88:987-93. 2001
  4. ncbi request reprint Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure
    Monica R Shah
    Duke Clinical Research Institute, P O Box 17969, Durham, NC 27715, USA
    Eur J Heart Fail 4:297-304. 2002
  5. ncbi request reprint Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)
    CHRISTOPHER M O'CONNOR
    Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 41:1452-7. 2003
  6. ncbi request reprint Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4)
    CHRISTOPHER M O'CONNOR
    Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 145:S58-9. 2003
  7. ncbi request reprint Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial
    Cynthia Binanay
    Duke Clinical Research Institute, Durham, NC, USA
    JAMA 294:1625-33. 2005
  8. ncbi request reprint Intensity and focus of heart failure disease management after hospital discharge
    Monica R Shah
    Division of Cardiology, Center for Advanced Cardiac Care, Columbia University Medical Center, Durham, NC, USA
    Am Heart J 149:715-21. 2005
  9. pmc Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial
    Vic Hasselblad
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Eur J Heart Fail 9:1064-9. 2007
  10. pmc High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization
    Larry A Allen
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    J Card Fail 14:661-9. 2008

Detail Information

Publications16

  1. ncbi request reprint Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale
    M R Shah
    Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA
    Am Heart J 141:528-35. 2001
    ..However, there is no consensus regarding the true utility of this strategy. A randomized clinical trial is needed to test the safety, efficacy, and treatment benefit of pulmonary artery catheterization in patients with advanced CHF...
  2. ncbi request reprint Hemodynamics as surrogate end points for survival in advanced heart failure: an analysis from FIRST
    M R Shah
    Duke Clinical Research Institute, Durham, NC 27715, USA
    Am Heart J 141:908-14. 2001
    ....
  3. ncbi request reprint Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy
    M R Shah
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    Am J Cardiol 88:987-93. 2001
    ..This may be a simple, noninvasive, objective way to risk-stratify these patients and standardize their treatment...
  4. ncbi request reprint Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure
    Monica R Shah
    Duke Clinical Research Institute, P O Box 17969, Durham, NC 27715, USA
    Eur J Heart Fail 4:297-304. 2002
    ..Changes in hemodynamic measures often serve as surrogate end points in efficacy trials for advanced heart failure, although there are few objective data to support this practice...
  5. ncbi request reprint Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)
    CHRISTOPHER M O'CONNOR
    Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    J Am Coll Cardiol 41:1452-7. 2003
    ..We sought to determine the effect of tezosentan in patients with acute decompensated heart failure (HF) associated with acute coronary syndrome (ACS)...
  6. ncbi request reprint Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4)
    CHRISTOPHER M O'CONNOR
    Duke University Medical Center and Duke Clinical Research Institute, Durham, NC 27705, USA
    Am Heart J 145:S58-9. 2003
  7. ncbi request reprint Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial
    Cynthia Binanay
    Duke Clinical Research Institute, Durham, NC, USA
    JAMA 294:1625-33. 2005
    ..Pulmonary artery catheters (PACs) have been used to guide therapy in multiple settings, but recent studies have raised concerns that PACs may lead to increased mortality in hospitalized patients...
  8. ncbi request reprint Intensity and focus of heart failure disease management after hospital discharge
    Monica R Shah
    Division of Cardiology, Center for Advanced Cardiac Care, Columbia University Medical Center, Durham, NC, USA
    Am Heart J 149:715-21. 2005
    ..Although features of heart failure disease management programs are broadly outlined, little is known about which interventions are actually used in the outpatient setting or which patients are most likely to require interventions...
  9. pmc Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial
    Vic Hasselblad
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Eur J Heart Fail 9:1064-9. 2007
    ..We examined the relation of maximal in-hospital diuretic dose to weight loss, changes in renal function, and mortality in hospitalised heart failure (HF) patients...
  10. pmc High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomization
    Larry A Allen
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    J Card Fail 14:661-9. 2008
    ..The external validity of these findings is debated...
  11. ncbi request reprint Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the Randomized Intravenous Tezosentan study (RITZ-4)
    CHRISTOPHER M O'CONNOR
    Duke University Medical Center and Duke Clinical Research Institute, Durham, University of North Carolina, Chapel Hill, NC 27705, USA
    Am Heart J 144:583-8. 2002
    ..Tezosentan is a dual endothelin receptor antagonist, and it has improved cardiac output and reduced pulmonary and systemic vascular resistance in experimental animal models and in initial human acute decompensated heart failure studies...
  12. ncbi request reprint Searching for evidence: Refractory questions in advanced heart failure
    Monica R Shah
    Duke Clinical Research Institute, Durham, North Carolina 27715, USA
    J Card Fail 10:210-8. 2004
    ..Despite ample data from randomized clinical trials (RCTs), the management of advanced heart failure (HF) varies greatly. We examined the most common refractory questions arising in routine inpatient management of advanced HF...
  13. ncbi request reprint Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality
    Michelle Kittleson
    Departments of Medicine and Cardiology, Brigham and Women s Hospital, 75 Francis Street, Boston, MA 02115, USA
    J Am Coll Cardiol 41:2029-35. 2003
    ..This study examined the hypothesis that patients who develop angiotensin-converting enzyme inhibitor intolerance attributable to circulatory-renal limitations (CRLimit) have more severe underlying disease and worse outcome...
  14. ncbi request reprint Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial)
    Monica R Shah
    Washington Hospital Center, MedStar Research Institute, Washington, DC, USA
    Am J Cardiol 100:1427-33. 2007
    ..BNP decreased after hospitalization, but correlated modestly with PAC-derived hemodynamics. Rapid-assay BNP may provide information that helps physicians decide when to pursue more aggressive and invasive therapies...
  15. ncbi request reprint Testing new targets of therapy in advanced heart failure: the design and rationale of the Strategies for Tailoring Advanced Heart Failure Regimens in the Outpatient Setting: BRain NatrIuretic Peptide Versus the Clinical CongesTion ScorE (STARBRITE) trial
    Monica R Shah
    Center for Advanced Cardiac Care, Columbia University Medical Center, New York, NY 10032, USA
    Am Heart J 150:893-8. 2005
  16. ncbi request reprint Use of pulmonary artery catheters in advanced heart failure
    Monica R Shah
    Heart Failure Research, Washington Hospital Center, Washington, District of Columbia 20010, USA
    Curr Opin Cardiol 22:220-4. 2007
    ..It also offers guidelines on when pulmonary artery catheter use could be considered in patients with advanced heart failure...